
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Therapeutic potential of recombinant IL-22BP in psoriasis: suppression of IL-22/STAT3 signaling in mice - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4BD3D8AF448F305BD3D0012BE7FAF.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ambex">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361007/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="AMB Express">
<meta name="citation_title" content="Therapeutic potential of recombinant IL-22BP in psoriasis: suppression of IL-22/STAT3 signaling in mice">
<meta name="citation_author" content="Xiuze Chen">
<meta name="citation_author_institution" content="Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China">
<meta name="citation_author" content="Tao Zeng">
<meta name="citation_author_institution" content="Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China">
<meta name="citation_author" content="Fang Fang">
<meta name="citation_author_institution" content="The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524023 China">
<meta name="citation_author" content="Qinyu Tian">
<meta name="citation_author_institution" content="Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China">
<meta name="citation_author" content="Yingying Li">
<meta name="citation_author_institution" content="Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China">
<meta name="citation_author" content="Wenlin Zhou">
<meta name="citation_author_institution" content="Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China">
<meta name="citation_author" content="Binqian Gong">
<meta name="citation_author_institution" content="Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China">
<meta name="citation_author" content="Na Tian">
<meta name="citation_author_institution" content="Jilin Tuohua Biotechnology Co., LTD, Siping, 136001 China">
<meta name="citation_author" content="Jizhou Zhang">
<meta name="citation_author_institution" content="Department of Biochemistry, College of Basic Medical Science, Jilin University, Changchun, 130021 China">
<meta name="citation_author" content="Yechen Xiao">
<meta name="citation_author_institution" content="Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="121">
<meta name="citation_doi" content="10.1186/s13568-025-01931-4">
<meta name="citation_pmid" content="40824430">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361007/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361007/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361007/pdf/13568_2025_Article_1931.pdf">
<meta name="description" content="Psoriasis is a persistent immune-mediated inflammatory disorder that adversely affects the skin. Interleukin-22 (IL-22) is integral to the development and pathophysiology of psoriasis, and targeting IL-22 may serve as a promising therapeutic ...">
<meta name="og:title" content="Therapeutic potential of recombinant IL-22BP in psoriasis: suppression of IL-22/STAT3 signaling in mice">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Psoriasis is a persistent immune-mediated inflammatory disorder that adversely affects the skin. Interleukin-22 (IL-22) is integral to the development and pathophysiology of psoriasis, and targeting IL-22 may serve as a promising therapeutic ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361007/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12361007">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13568-025-01931-4"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13568_2025_Article_1931.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12361007%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12361007/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12361007/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361007/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ambex.jpg" alt="AMB Express logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to AMB Express" title="Link to AMB Express" shape="default" href="http://www.amb-express.com" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">AMB Express</button></div>. 2025 Aug 18;15:121. doi: <a href="https://doi.org/10.1186/s13568-025-01931-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13568-025-01931-4</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22AMB%20Express%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22AMB%20Express%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22AMB%20Express%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22AMB%20Express%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Therapeutic potential of recombinant IL-22BP in psoriasis: suppression of IL-22/STAT3 signaling in mice</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Xiuze Chen</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Xiuze Chen</span></h3>
<div class="p">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiuze Chen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zeng%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Tao Zeng</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Tao Zeng</span></h3>
<div class="p">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zeng%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tao Zeng</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fang%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Fang Fang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Fang Fang</span></h3>
<div class="p">
<sup>2</sup>The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524023 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fang%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fang Fang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Qinyu Tian</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Qinyu Tian</span></h3>
<div class="p">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qinyu Tian</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yingying Li</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yingying Li</span></h3>
<div class="p">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yingying Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Wenlin Zhou</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Wenlin Zhou</span></h3>
<div class="p">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenlin Zhou</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gong%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Binqian Gong</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Binqian Gong</span></h3>
<div class="p">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gong%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Binqian Gong</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Na Tian</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Na Tian</span></h3>
<div class="p">
<sup>3</sup>Jilin Tuohua Biotechnology Co., LTD, Siping, 136001 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Na Tian</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jizhou Zhang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Jizhou Zhang</span></h3>
<div class="p">
<sup>4</sup>Department of Biochemistry, College of Basic Medical Science, Jilin University, Changchun, 130021 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jizhou Zhang</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Yechen Xiao</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Yechen Xiao</span></h3>
<div class="p">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yechen Xiao</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Biotechnology, Basic Medical School, Guangdong Medical University, Dongguan, 523808 China </div>
<div id="Aff2">
<sup>2</sup>The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524023 China </div>
<div id="Aff3">
<sup>3</sup>Jilin Tuohua Biotechnology Co., LTD, Siping, 136001 China </div>
<div id="Aff4">
<sup>4</sup>Department of Biochemistry, College of Basic Medical Science, Jilin University, Changchun, 130021 China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 7; Accepted 2025 Aug 3; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12361007  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40824430/" class="usa-link">40824430</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Psoriasis is a persistent immune-mediated inflammatory disorder that adversely affects the skin. Interleukin-22 (IL-22) is integral to the development and pathophysiology of psoriasis, and targeting IL-22 may serve as a promising therapeutic approach for treating the condition. IL-22 binding protein (IL-22BP) exhibits a binding affinity for IL-22 that far surpasses that of IL-22RA1 and functions as a natural antagonist of IL-22. Traditional IL-22BP production methods predominantly rely on eukaryotic animal cell expression systems, which generally require complex processes, resulting in low yield and high production costs. This study reports the expression of long-acting IL-22BP with a high yield and purity over 90% in <em>Escherichia coli</em> by fusion with the albumin-binding structural domain ABD. The biological functions of rhIL-22BP-ABD were assessed utilizing cell lines and a murine model. Our findings indicated that rhIL-22BP-ABD successfully suppressed IL-22-induced proliferation of HaCaT cells in vitro and alleviated imiquimod-induced psoriasis inflammation in mice. Furthermore, rhIL-22BP-ABD can effectively inhibit the signaling of its downstream signaling pathway STAT3 and the associated inflammatory factors by binding to IL-22, which is beneficial to the recovery of psoriasis. These findings provide a basis for forthcoming extensive studies on the rhIL-22BP-ABD protein for industrial manufacturing and pharmaceutical development.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13568-025-01931-4.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> IL-22, rhIL-22BP-ABD, Renaturation of inclusion body, Psoriasis</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Psoriasis is an immune-mediated inflammatory disorder marked by autoimmune pathology impacting the skin and joints. The worldwide frequency of psoriasis is believed to be between 2% and 3% (Gibbs <a href="#CR13" class="usa-link" aria-describedby="CR13">1996</a>; Parisi et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2013</a>). Psoriasis is defined by the rapid proliferation and atypical differentiation of keratinocytes, presenting clinically as erythematous squamous plaques of varying sizes. It is associated with numerous other health issues, including psoriatic arthritis, metabolic syndrome, cardiovascular disorders, diabetes, and various comorbidities (Owen et al. <a href="#CR33" class="usa-link" aria-describedby="CR33">2000</a>; Perera et al. <a href="#CR36" class="usa-link" aria-describedby="CR36">2012</a>; Schön and Boehncke <a href="#CR39" class="usa-link" aria-describedby="CR39">2005</a>). Recent years have witnessed substantial advancements in the studies about the pathophysiology of psoriasis. Research indicates that psoriasis is regulated by intricate connections between external cytokine pathways and intracellular signaling molecules (Sieminska et al. <a href="#CR40" class="usa-link" aria-describedby="CR40">2024</a>). A range of cytokines convey extracellular signals to the cell membrane, subsequently acknowledged by the appropriate receptors (Petit et al. <a href="#CR37" class="usa-link" aria-describedby="CR37">2021</a>). This process activates intracellular signaling pathways and triggers a sequence of events, ultimately culminating in an inflammatory signal cascade. The TNF/IL-23/ IL-17 pathway plays a pivotal role in the development of psoriasis (Guo et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>). A range of pharmacological inhibitors has been formulated to target this pathway, including adalimumab, etanercept, infliximab, IL-17 inhibitors, IL-23 inhibitors, and others. Notwithstanding the early effectiveness of these drugs, obstacles and restrictions in their utilization endure. This primarily results from certain patients’ lack of response to these treatments, resulting in treatment failure, the generation of neutralizing antibodies in patients after repeated use, and the exorbitant cost of therapeutic agents, which presents a significant challenge to both patients and the healthcare system (Lee and Kim <a href="#CR20" class="usa-link" aria-describedby="CR20">2023</a>).</p>
<p id="Par3">IL-22 is a member of the IL-10 family, an it can be produced by several immune cells, including Th17 cells, Th22 cells, γδT cells, and NK cells (Fujita et al. <a href="#CR10" class="usa-link" aria-describedby="CR10">2009</a>; Tokura et al. <a href="#CR41" class="usa-link" aria-describedby="CR41">2010</a>). Secreted IL-22 exerts its effects on target cells via binding to IL-22R1, which is primarily expressed on non-immune cells, such as keratinocytes (Wolk et al. <a href="#CR48" class="usa-link" aria-describedby="CR48">2004</a>). IL-22 expression is heightened in psoriasis lesions and contributes to acanthosis nigricans by suppressing keratinocyte differentiation, representing a distinctive feature of psoriasis-like epidermal inflammation (Wolk et al. <a href="#CR47" class="usa-link" aria-describedby="CR47">2009</a>). Consequently, IL-22 is considered a possible target for psoriasis treatment.</p>
<p id="Par4">The IL-22 receptor is a heterodimeric complex of IL-22R1 and IL-10R2. It contains three major domains: extracellular, transmembrane, and intracellular signaling regions (Bleicher et al. <a href="#CR4" class="usa-link" aria-describedby="CR4">2008</a>; Xie et al. <a href="#CR50" class="usa-link" aria-describedby="CR50">2000</a>). IL-22 initially binds to the IL-22R1 subunit and the resulting complex undergoes a conformational change followed by IL-10R2 binding, thereby initiating a downstream signaling cascade (Li et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2004</a>), after forming a complex with IL-10R2, activator of transcription 3 (STAT3 phosphorylation) is triggered by activated Janus kinase (JAK) and tyrosine kinase 2 (Tyk2). Not only that, IL-22 also activates the kinases p38, MEK/ERK1/2 and JNK (Lejeune et al. <a href="#CR21" class="usa-link" aria-describedby="CR21">2002</a>; Nagalakshmi et al. <a href="#CR29" class="usa-link" aria-describedby="CR29">2004</a>), which distinguishes it from other IL-10 related cytokines.</p>
<p id="Par5">IL-22 binding protein (IL-22BP/IL-22RA2) is a secretory protein with a total length of 231 amino acids (Jones et al. <a href="#CR16" class="usa-link" aria-describedby="CR16">2008</a>). Although structurally akin to the IL-22R1 chain, the affinity of IL-22BP for IL-22 is 20 to 1000 times higher than that of IL-22R1 (Khawar et al. <a href="#CR19" class="usa-link" aria-describedby="CR19">2016</a>; Pelczar et al. <a href="#CR35" class="usa-link" aria-describedby="CR35">2016</a>). Some studies showed that the dissociation constant between IL-22 and IL-22BP was 1 pM, and the dissociation constant between IL-22 and IL-22R1 was 20 nM. The corresponding dissociation rate constants of the two conjugates were 4.7 d and 7.4 min, respectively (Jones et al. <a href="#CR16" class="usa-link" aria-describedby="CR16">2008</a>), therefore obstructing IL-22 interaction with IL-22R1 (Mühl and Bachmann <a href="#CR28" class="usa-link" aria-describedby="CR28">2019</a>). Numerous studies have shown that a deficit in IL-22BP results in the upregulation of IL-22, consequently worsening psoriasis (Voglis et al. <a href="#CR43" class="usa-link" aria-describedby="CR43">2018</a>). Research indicates that patients with psoriasis exhibit elevated levels of IL-22 and reduced levels of IL-22BP compared to healthy individuals (Martin et al. <a href="#CR26" class="usa-link" aria-describedby="CR26">2017</a>). Moreover, the modulation of IL-22 signaling via autocrine IL-22BP synthesis in keratinocytes aids in the preservation of skin homeostasis (Fukaya et al. <a href="#CR11" class="usa-link" aria-describedby="CR11">2018</a>). Research on animal models of skin inflammation has elucidated the protective function of IL-22BP, demonstrating a significant downregulation of IL-22BP mRNA in imiquimod-induced skin inflammation models, which therefore worsens the condition (Voglis et al. <a href="#CR43" class="usa-link" aria-describedby="CR43">2018</a>). A comparable study demonstrated that administering a recombinant IL-22BP-Fc fusion protein to mice mitigated cutaneous inflammation and decreased the expression of inflammatory cytokine genes (Fukaya et al. <a href="#CR11" class="usa-link" aria-describedby="CR11">2018</a>).</p>
<p id="Par6">The albumin-binding domain (ABD) is derived from streptococcal protein G and is a compact three-helix protein domain consisting of 46 amino acids, with a molecular weight of approximately 5.2 kilodaltons (Altai et al. <a href="#CR2" class="usa-link" aria-describedby="CR2">2018</a>; Jonsson et al. <a href="#CR17" class="usa-link" aria-describedby="CR17">2008</a>). It can interact with human serum albumin (HSA), the predominant plasma protein with a half-life of roughly 19 days. Numerous studies have proven the importance of ABD fusion in extending the half-life of polypeptide and protein therapeutics (Liu et al. <a href="#CR24" class="usa-link" aria-describedby="CR24">2022</a>). This study involved the production of a long-acting rhIL-22BP-ABD fusion protein, which incorporates IL-22BP and ABD, utilizing the <em>E. coli</em> expression system. The resultant fusion protein demonstrates prolonged in vivo lifespan and exhibits significant biological activity both in vitro and in vivo. These findings lay the groundwork for extensive industrial manufacturing and pharmacological advancement of rhIL-22BP-ABD protein in the future.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Materials, strains and plasmids</h3>
<p id="Par7">Tryptone and yeast extract were acquired from Oxoid (Basingstoke, UK). Restriction endonucleases <em>Nde</em> I and <em>Xho</em> I, ampicillin antibiotic, Ni-NTA agarose resin, and SDS-PAGE precast gel kit were acquired from Yeasen (Shanghai, China). Imidazole and Isopropyl-β-D-thiogalactopyranoside (IPTG) were acquired from Solarbio (Beijing, China). BCA assay kit and HRP-labeled goat anti-rabbit secondary antibody were procured from Beyotime (Shanghai, China). A three-color pre-stained protein marker was acquired from Thermo (Waltham, MA, USA). Human IL-22 (Cat# HY-P7039) was acquired from MCE (New Jersey, USA). Anti-histidine antibody (Cat# T0009), anti-IL-22 antibody (Cat# DF8343), anti-phosphorylated STAT3 antibody (Cat# AF3293), and anti-STAT3 antibody (Cat# AF6294) were acquired from Affinity (Cincinnati, Ohio, USA). TNF-α ELISA kit (Cat# EK282HS) and IL-6 ELISA kit (Cat# EK206) were purchased from MultiSciences Biotech Co., Ltd (Hangzhou, China). <em>E. coli</em> BL21 (DE3) and <em>E. coli</em> DH5α were preserved and manufactured in our laboratory.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Construction of recombinant plasmids</h3>
<p id="Par8">Based on the protein sequence of interleukin-22 receptor subunit alpha-2 (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_851826" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_851826</a>) in the NCBI database, rhIL-22BP-ABD was synthesized utilizing the preferred codon of <em>E. coli</em> (Supplementary file 1: Data 1, Data 2) and subsequently cloned between the <em>Nde</em> I and <em>Xho</em> I cleavage sites of the pET-20b(+) vector by IGE Biotechnology Co. (Guangzhou, China). Utilizing rhIL-22BP-ABD as a template, rhIL-22BP was amplified via PCR and subsequently cloned into the plasmid pET20b to create the recombinant plasmid pET20b-rhIL-22BP (Supplementary file 1: Data 3). The recombinant plasmid was introduced into <em>E. coli</em> BL21 (DE3) cells, and the recombinant strain was cultivated on LB solid medium at 37 ℃ for 12–16 h. Individual colonies were isolated from the solid medium and cultivated in LB liquid media by shaking at 37 ℃ at 200 rpm overnight. The activated bacterial solution was inoculated into LB liquid medium at a 1:100 ratio and incubated at 37 ℃ with shaking at 200 rpm until the OD600 value reached 0.6–0.8. IPTG was introduced to achieve a final concentration of 0.5 mM and incubated at 37 ℃ for 5 h. The expression of recombinant proteins was evaluated using 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).</p></section><section id="Sec5"><h3 class="pmc_sec_title">Soluble assay of rhIL-22BP-ABD and rhIL-22BP</h3>
<p id="Par9">The engineered bacteria harboring pET20b-rhIL-22BP-ABD and pET20b-rhIL-22BP were inoculated and cultured in LB liquid medium at 37 ℃ in a shaker until the OD600 value attained 0.6–0.8. IPTG was introduced at a final concentration of 0.5 mM, and the induction incubation was conducted at 37 ℃ for 5 h. The recombinant bacteria underwent centrifugation and sonication to disrupt and release the proteins into a 20 mM Tris-HCl buffer. The supernatant containing soluble proteins was centrifuged at 12,000 rpm for 15 min at 4 ℃. The resultant precipitate was subsequently resuspended in an equivalent volume of buffer. The samples were subsequently analyzed for soluble protein expression using SDS-PAGE.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Optimization of the expression conditions induced by rhIL-22BP-ABD</h3>
<p id="Par10">To determine the best concentration of IPTG while keeping other variables constant, varying final concentrations of IPTG (0, 0.3, 0.5, 0.7, 1 mM) were introduced to the LB medium and incubated for 5 h at 37 ℃. The total protein of the stimulated bacteria was assessed via 12% SDS-PAGE to ascertain the appropriate IPTG concentration. Correspondingly, various temperatures (16 ℃, 20 ℃, 30 ℃, 37 ℃) were established to elicit the expression of recombinant protein, and samples were subjected to electrophoresis post-expression to ascertain the optimal induction temperature. To ascertain the best induction duration, IPTG was introduced to a final concentration of 0.5 mM, and the recombinant bacteria were incubated at 37 ℃ for 3, 4, 5, 6, 7, and 8 h. The expression of recombinant proteins was evaluated via 12% SDS-PAGE to ascertain the appropriate induction duration.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Acquisition and denaturation of inclusion bodies</h3>
<p id="Par11">Under ideal circumstances for inclusion body protein expression (OD value of 0.6–0.8, induced by 0.5 mM IPTG at 37 ℃ for 6 h), the organisms were harvested via centrifugation at 12,000 rpm for 10 min post-induction, followed by ultrasonic disruption at 500 W for 30 min. The supernatant was removed, and the precipitate was resuspended in the designated volume of inclusion body washing solution. It was agitated for 20 min at 4 ℃, followed by centrifugation at 12,000 rpm for 15 min, after which the supernatant was discarded. This process was done three times. The precipitate was rewashed with a suitable volume of 20 mM Tris-HCl buffer (pH 8.0), centrifuged at 12,000 rpm for 30 min at 4 ℃, and the supernatant was discarded to isolate pure protein inclusion bodies. The inclusion bodies were denatured and solubilized in 6 M or 8 M urea solutions by repeated agitation, denatured for 4 h at 4 ℃, and subsequently centrifuged at 12,000 rpm for 30 min to determine the optimal urea concentration for denaturation. The supernatant was collected to obtain the soluble protein solution for further purification.</p></section><section id="Sec800"><h3 class="pmc_sec_title">Purification and renaturation of rhIL-22BP-ABD inclusion body</h3>
<p id="Par12">The denatured supernatant of rhIL-22BP-ABD was purified using Ni-NTA affinity chromatography. The Ni-NTA resin was rinsed with lysis buffer (pH 8.0) containing 10 mM imidazole and 8 M urea until the OD280 value aligned with the baseline level. The protein supernatant was incubated with the Ni-NTA column for 0.5 to 1 h. Thereafter, nonspecifically bound heteroproteins were eliminated using a wash buffer composed of 40 mM imidazole and 8 M urea at pH 8.0. The target protein was ultimately eluted using an elution buffer of 250 mM imidazole and 8 M urea at pH 8.0. The purity of the recombinant proteins was assessed using 12% SDS-PAGE, and their quantity was quantified with a BCA protein assay kit.</p>
<p id="Par13">To investigate the optimal complexation scheme, the supernatant of the purified denatured proteins was divided into two equal portions. The first portion was placed in a dialysis bag (with a cut-off molecular weight of 3500 D) and subsequently immersed in a 5-fold volume of gradient complexation buffer containing 6, 4, 2, 1, and 0 M urea (20 mM Tris-HCl, 50 mM NaCl, 0.5 mM GSSG, 1.0 mM GSH, pH 8.0), and dialyzed at 4 ℃ for a minimum of 12 h for each gradient. At the conclusion of each gradient, 40 µL of the sample was aliquoted for preparation and reserved, and following dialysis, all gradient samples underwent 12% SDS-PAGE electrophoresis to assess complexation efficiency. The second protein supernatant was transferred into a dialysis bag (with a cut-off molecular weight of 3500 Da) and subsequently placed into a urea gradient complexation buffer comprising 4 M (with 2 mM DTT) and 0 M urea gradient complexation buffer (with 0.5 mM DTT) at a volume five times greater. Dialysis was conducted at 4 ℃ for a minimum of 12 h for each gradient, and at the conclusion of each gradient, 40 µL of the sample was extracted for preparation and reserved. Post-dialysis, all gradient samples underwent 12% SDS-PAGE to assess complexation efficiency. The protein acquired post-complexation was subjected to centrifugation at 4 ℃ and 12,000 rpm for 15 min, after which the supernatant was filtered and sterilized, subsequently distributed and preserved in a -80 ℃ freezer.</p></section><section id="Sec801"><h3 class="pmc_sec_title">Identification of rhIL-22BP-ABD</h3>
<p id="Par14">Western blotting was conducted to ascertain the purified rhIL-22BP-ABD. Protein samples mixed with 5×protein loading buffer were subjected to boiling in a water bath and subsequently separated using 12% SDS-PAGE. The isolated proteins were subsequently transferred to a PVDF membrane and incubated with 5% skim milk for 2 h to inhibit non-specific binding sites. Thereafter, the membrane was treated with His-tag polyclonal antibody (1:1000 dilution), followed by washing and incubation with horseradish peroxidase-conjugated secondary antibody (1:1000 dilution). Immunoreactive bands were seen utilizing an ECL chemiluminescence detection kit.</p>
<p id="Par15">The amino acid content of rhIL-22BP-ABD was analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) by APTBIO in Shanghai, China.</p></section><section id="Sec802"><h3 class="pmc_sec_title">In vitro activity assay of rhIL-22BP-ABD</h3>
<p id="Par16">To evaluate the biological activity of rhIL-22BP-ABD, HaCaT cells were incubated at 37 ℃ in a 5% CO<sub>2</sub> atmosphere using DMEM media supplemented with 10% fetal bovine serum. Cultured cells were inoculated into 96-well plates (3,000–5,000 cells per well) with varying doses of rIL-22, and cell proliferation was assessed using the CCK8 kit after 12 h of incubation. Following the identification of the optimal concentration for IL-22 stimulation, HaCaT cells were grown in 96-well plates (3000–5000 cells per well) with 10 ng/mL rIL-22 and varying concentrations of rhIL-22BP-ABD. The DMEM medium group devoid of rIL-22 and rhIL-22BP-ABD served as a blank control, whereas the DMEM medium group containing rIL-22 without rhIL-22BP-ABD functioned as a negative control. The cell proliferation was assessed using the CCK8 kit following 12 h of incubation.</p></section><section id="Sec804"><h3 class="pmc_sec_title">Determination of kinetic binding parameters of rhIL-22BP-ABD and human serum albumin</h3>
<p id="Par17">Due to both rhIL-22BP-ABD and rhIL-22BP possessing a 6×His tag, His-Tag pull-down assays were employed to ascertain the interaction between rhIL-22BP-ABD and HSA. The His tag purification resin was first thoroughly washed five times and equilibrated with 20 mM Tris-HCl (pH = 8.0). The purified rhIL-22BP-ABD and rhIL-22BP were incubated with His tag purification resin in a rotating incubator at 4℃ for 30 min, after which the resin was collected and washed three times. Dissolve 0.2 mg/mL of HSA in the reaction buffer (20 mM Tris, 0.5 mM DTT, pH 8.0) and incubate with the column material in a rotary incubator at 4℃ for 30 min. Subsequent to the removal of the supernatant, the resin was subjected to four washes with the reaction buffer. The target protein was washed and separated using 10% SDS. The eluents were subsequently tested and detected using 12% SDS-PAGE.</p>
<p id="Par18">The molecular interaction approach was utilized to evaluate the kinetic binding characteristics of rhIL-22BP-ABD and HSA by a BLI experiment employing the Octet system. All proteins were diluted in 20 mM Tris-HCl with 0.5 mM DTT. The his-tagged rhIL-22BP-ABD structural domain (100 µg/mL) was initially adsorbed on the biosensor (ForteBio) and equilibrated with 20 mM Tris-HCl. The biosensor was subsequently exposed to HSA and rinsed with 0 M urea buffer. Relevant parameters were set as follows: Baseline 1 (180 s), Loading (300 s), Baseline 2 (180 s), Association (600 s), Dissociation (600 s). The ultimate binding affinity (Kd) was determined using data analysis software (Octet<sup>®</sup> BLI Analysis 12). In brief, the Data were first processed in Data Correction using Y-axis alignment, inter-step correction, and Savitzky-Golay filtering. Dissociation and binding data were analyzed under Options. Secondly, the quality of fitting data was evaluated, and judged according to the quantitative difference between Ka (Association Constant), Kd (Dissociation Constant), and their corresponding error values, R2 (Measure the degree of conformity between the fitted curve and the actual measurement lines), X2 (Measure the difference between the fitted curve and the measured curve) and other parameters.</p></section><section id="Sec805"><h3 class="pmc_sec_title">In vivo half-life determination of rhIL-22BP-ABD</h3>
<p id="Par19">All animal experiments conducted in this article were approved by the Laboratory Animal Ethics Committee of Guangdong Medical University. To detect pharmacokinetic analysis of rhIL-22BP-ABD, five female BALB/c mice (18–20 g) were taken for a single subcutaneous injection of 5 mg/kg rhIL-22BP-ABD, and post-injection at 0.2, 1, 2, 4, 8, 12, 24, 36, 48 and 60 h blood collection. After standing at room temperature for 1 h, the serum was centrifuged at 4 ℃ and 3500 rpm, and the serum level of rhIL-22BP-ABD was detected by the human IL-22BP enzyme-linked immunosorbent assay kit (Byabscience, Nanjing, China). rhIL-22BP was used as a negative control. The half-life was calculated by using the Microsoft Excel plug-in “PKSolver”.</p></section><section id="Sec807"><h3 class="pmc_sec_title">Therapeutic effects of rhIL-22BP-ABD on psoriasis in mice</h3>
<p id="Par20">The psoriasis mouse model was developed in accordance with the pertinent literature (Li et al. <a href="#CR23" class="usa-link" aria-describedby="CR23">2022</a>). Psoriasis was generated with the application of 5% imiquimod cream on the depilated dorsal skin for 9 consecutive days, alongside intraperitoneal injections of varying concentrations of rhIL-22BP-ABD or 0 M urea in a compounded solution for the same duration. In brief, twenty female BALB/c mice (18–20 g) were randomly allocated into four groups (<em>n</em> = 5): control group (coated with vaseline, i.p. 0 M urea in replica solution), model group (coated with 5% imiquimod cream, i.p. 0 M urea in replica solution), cream + 10 mg/kg rhIL-22BP-ABD group (coated with 5% imiquimod cream, i.p. 10 mg/kg rhIL-22BP-ABD), and cream + 5 mg/kg rhIL-22BP-ABD group (coated with imiquimod cream, i.p. 5 mg/kg rhIL-22BP-ABD). The alterations in body weight and dorsal dander attributes of the mice were meticulously observed and documented on a regular basis during the trial. At the conclusion of the experimental phase, the mice were killed to obtain dorsal skin samples for subsequent study. The spleens were weighed, photographed, and the spleen index was computed. PASI scores for the modeled skin on the backs of all mice in each group were assessed and recorded daily. To be precise, erythema, scaling and thickeness were independently scored on a scale of 0 to 4 (0, none; 1, mild; 2, moderate; 3, marked; 4, very marked), and the cumulative score is the total score (scale 0–12). The severity of the disease was assessed by pathology technical experts in a blinded manner. At the conclusion of the administration, the in vivo efficacy of rhIL-22BP-ABD was evaluated by measuring spleen size and associated organ indices in the mice, as well as assessing the dorsal modeling skin using western blot and HE staining.</p></section><section id="Sec808"><h3 class="pmc_sec_title">Histopathological analysis</h3>
<p id="Par21">To evaluate the degree of skin tissue damage, dorsal skin samples were obtained from each group of mice post-euthanasia. Skin tissues measuring approximately 0.5 cm² were fixed in 4% paraformaldehyde for 24 h, embedded in paraffin wax, sectioned to a thickness of 5 μm, and stained with hematoxylin-eosin (H&amp;E). A pathologist conducted histologic investigation of the stained sections in a single-blind way. The extent of skin injury was evaluated with a double-blind methodology.</p></section><section id="Sec810"><h3 class="pmc_sec_title">Analysis of inflammatory factors by ELISA</h3>
<p id="Par22">Before the mice were sacrificed, blood was collected from the eye socket into clean centrifuge tubes. The tubes were left at 4℃ for 1 to 2 h, then centrifuged at 3000 rpm for 15 min to obtain the serum. The expression levels of inflammatory factors IL-6 and TNF-α in the mouse serum were detected according to the instructions of the ELISA assay kit (MultiSciences Biotech Co.,Ltd., China).</p></section><section id="Sec655"><h3 class="pmc_sec_title">Western blot analysis</h3>
<p id="Par23">Small slices of skin tissue, weighing around 50–100 mg, were excised, frozen in liquid nitrogen, and subsequently lysed in RIPA protein lysis buffer. The supernatant was centrifuged at 12,000 rpm for 20 min at 4 ℃, and the protein content was measured using a BCA kit. The protein was extracted using 12% SDS-PAGE and subsequently transferred from the gel to a PVDF membrane (Millipore, USA). The non-specific binding was inhibited by incubating the membrane with 5% skimmed milk for 2 h. Following blocking, the membranes were treated with particular antibodies overnight at 4 ℃, subsequently washed, and then incubated with secondary antibodies. The pertinent bands were generated with an ECL luminescence kit.</p></section><section id="Sec811"><h3 class="pmc_sec_title">Statistical analysis of data</h3>
<p id="Par24">All experimental data were statistically analyzed using GraphPad Prism 9.0 software. The statistical method was analysis of one-way analysis of variance(ANOVA) and the results were expressed as mean ± standard deviation (SD). A <em>P</em> value less than 0.05 was considered statistically significant.</p></section></section><section id="Sec16"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec17"><h3 class="pmc_sec_title">The inducible expression of rhIL-22BP-ABD in E. coli</h3>
<p id="Par25">The recombinant plasmid comprising pET20b-rhIL-22BP-ABD and pET20b-rhIL-22BP was constructed and manufactured as depicted in Fig. <a href="#Fig1" class="usa-link">1</a>A, respectively. The two accurately identified recombinant plasmids were transformed into <em>E. coli</em> BL21(DE3) and stimulated with IPTG at 37 ℃ at a final dose of 0.5 mM for 5 h. The empty vector pET20b served as a negative control concurrently. The protein expression was evaluated using 12% SDS-PAGE, revealing that rhIL-22BP-ABD (35 kDa) and rhIL-22BP (25 kDa) were specifically expressed in contrast to the empty vector; however, these proteins predominantly manifested as inclusion bodies in the precipitate following bacterial lysis (Fig. <a href="#Fig1" class="usa-link">1</a>B-D).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361007_13568_2025_1931_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12361007/95c6d02fe661/13568_2025_1931_Fig1_HTML.jpg" loading="lazy" id="d33e472" height="549" width="784" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The Design and expression of rhIL-22BP-ABD and rhIL-22BP in <em>E. coli</em>. <strong>A</strong> Schematic diagram of the construction of rhIL-22BP-ABD and rhIL-22BP recombinant plasmids. <strong>B</strong> The induced expression of rhIL-22BP-ABD. M represents marker, lane 1 represents the total protein of blank bacteria containing pET20b before induction, lane 2 represents the total protein of blank bacteria containing pET20b after induction, and lane 3 represents the total protein of recombinant bacteria containing pET20b-rhIL-22BP-ABD before induction, lane 4 represents the total protein of recombinant bacteria containing pET20b-rhIL-22BP-ABD after induction. lane 5 represents the supernatant of recombinant bacteria containing pET20b-rhIL-22BP-ABD after induction and ultrasonic disruption and lane 6 represents the precipitate of recombinant bacteria containing pET20b-rhIL-22BP-ABD after induction and ultrasonic disruption. <strong>C</strong> The induced expression of rhIL-22BP. M represents marker, lane 1 represents the total protein of the blank bacteria containing pET20b before induction, lane 2 represents the total protein of blank bacteria containing pET20b after induction, lane 3 represents the total protein of recombinant bacteria containing pET20b-rhIL-22BP before induction, and lane 4 represents the total protein of recombinant bacteria containing pET20b-rhIL-22BP after induction. lane 5 represents the supernatant of recombinant bacteria containing pET20b-rhIL-22BP after induction and ultrasonic disruption, and lane 6 represents the precipitate of recombinant bacteria containing pET20b-rhIL-22BP after induction and ultrasonic disruption. <strong>D</strong> Comparison diagram of rhIL-22BP-ABD and rhIL-22BP inclusion bodies by SDS-PAGE. M represents marker, lane 1 represents rhIL-22BP-ABD inclusion body, lane 2 represents rhIL-22BP inclusion body</p></figcaption></figure></section><section id="Sec18"><h3 class="pmc_sec_title">The optimization of inducible expression conditions of rhIL-22BP-ABD by SDS-PAGE analysis</h3>
<p id="Par27">To attain elevated expression levels of rhIL-22BP-ABD, the induction conditions were optimized across four dimensions: selection of high-expression strains, induction temperature, IPTG concentration, and induction duration. Figure <a href="#Fig2" class="usa-link">2</a>A illustrates that three individual colonies were chosen from the successfully transformed plates for induction expression under identical conditions. The results indicated that strain No. 2 exhibited a superior expression level and was utilized as the primary strain for subsequent condition optimization. Figure <a href="#Fig2" class="usa-link">2</a>B indicates that optimal protein expression occurred at 37 ℃ under 0.5 mM IPTG induction for a duration of 6 h. In a similar manner, maintaining constant induction temperature and time while establishing a series of inducer concentration gradients revealed that the optimal expression of the target protein occurred at an IPTG concentration of 0.5 mM (Fig. <a href="#Fig2" class="usa-link">2</a>C). The peak expression of the target protein was seen at 37 ℃ by varying the induction temperature under identical conditions (Fig. <a href="#Fig2" class="usa-link">2</a>D). To ascertain if low temperature enhances the soluble expression of recombinant proteins, we further reduced the induction temperature to 16 ℃, which revealed that the target proteins remained in the inclusion bodies (Fig. <a href="#Fig2" class="usa-link">2</a>E). These tests revealed that the optimal expression of the target protein rhIL-22BP-ABD occurred at 37 ℃ with a 0.5 mM IPTG concentration for 6 h.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361007_13568_2025_1931_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12361007/7781f23490da/13568_2025_1931_Fig2_HTML.jpg" loading="lazy" id="d33e517" height="495" width="784" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The optimization of induced expression conditions of rhIL-22BP-ABD by SDS-PAGE analysis. <strong>A</strong> Screening of optimal expression strains. Lane 1, 3 and 5 represent the total protein of bacterial strains No. 1, 2 and 3 before induction, respectively; lane 2, 4, and 6 represent the total protein of bacterial strains No.1, 2 and 3 after induction, respectively. <strong>B</strong> The effect of induction time on the expression of recombinant protein. M represents protein markers, lane 1 represents total protein before IPTG induction, and lanes 2 to 7 represent total protein after 0.5 mM IPTG induction at 37 ℃ for 3, 4, 5, 6, 7 and 8 h, respectively. <strong>C</strong> The effect of IPTG concentration on the expression of recombinant protein. M represents protein markers; lane 1 represents total protein before IPTG induction; lanes 2 to 6 represents total protein after 0, 0.3, 0.5, 0.7 and 1 mM IPTG induction, respectively. <strong>D</strong> The effect of induction temperature on the expression of recombinant protein. M represents protein markers, lane 1 represents total protein before IPTG induction, and lanes 2 to 4 represent total protein after 0.5 mM IPTG induction at 20℃, 30℃ and 37℃, respectively. <strong>E</strong> The expression of recombinant proteins at a low temperature of 16℃. M is protein markers, lane 1 represents the total protein of the bacteria before induction, lane 2 represents the total protein of the bacteria after induction, lane 3 represents the supernatant of recombinant bacteria containing pET20b-rhIL-22BP-ABD after induction and ultrasonic disruption, and lane 4 represents the precipitate of recombinant bacteria containing pET20b-rhIL-22BP-ABD after induction and ultrasonic disruption</p></figcaption></figure></section><section id="Sec19"><h3 class="pmc_sec_title">The treatment and purification of rhIL-22BP-ABD inclusion bodies</h3>
<p id="Par29">Given that rhIL-22BP-ABD manifests as inclusion bodies at an expression temperature of 37 ℃, these inclusion bodies must be denatured into soluble proteins prior to further investigations. Figure <a href="#Fig3" class="usa-link">3</a>A illustrates that the concentration of denatured supernatant protein derived from an 8 M urea denaturation treatment exceeded that obtained from an initial treatment of the inclusion body with 6 M urea. The concentration of the protein solution after renaturation with 8 M urea is greater than that of the protein solution after renaturation with 6 M urea. We employed Ni-NTA affinity chromatography to purify denatured rhIL-22BP-ABD, owing to the presence of a 6×His tag at its C-terminus. Figure <a href="#Fig3" class="usa-link">3</a>B depicts the elution of rhIL-22BP-ABD from the Ni-NTA column utilizing a Tris-HCl buffer with 250 mM imidazole (pH = 8.0), achieving a protein purity of around 90%.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361007_13568_2025_1931_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12361007/6d0f05f8c7d0/13568_2025_1931_Fig3_HTML.jpg" loading="lazy" id="d33e553" height="413" width="784" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The inclusion body treatment and purification of rhIL-22BP-ABD. <strong>A</strong> Denaturation effect of different concentrations of urea on inclusion bodies. M represents protein markers, lane 1 represents the untreated inclusion bodies, lane 2 represents 6 M denatured and renatured to 0 M urea protein precipitation, lane 3 represents the 6 M-denatured protein supernatant refolded to 0 M urea, lane 4 represents the protein precipitation of inclusion bodies denatured to 6 M urea, lane 5 represents the protein supernatant of inclusion bodies denatured to 6 M urea, lane 6 represents the protein precipitation of 8 M denatured to 0 M urea, lane 7 represents the protein supernatant of 8 M denatured to 0 M urea. Lane 8 represents the protein precipitation of inclusion bodies denatured with 8 M urea, and lane 9 represents the protein supernatant of inclusion bodies denatured with 8 M urea. <strong>B</strong> SDS-PAGE analysis of the purification of recombinant rhIL-22BP-ABD by Ni-NTA. M represents protein markers; lane 1 represents protein before purification; lanes 2 to 4 represent protein after purification by 40 mM iminazole elution; lanes 5 to 8 represent protein after purification by 250 mM iminazole elution. <strong>C</strong> The reduction of rhIL-22BP-ABD using GSSG/GSH redox. M represents protein marker, lane 1 represents the denatured supernatant of rhIL-22BP-ABD, lanes 2–5 represent purified rhIL-22BP-ABD and 4, 2, 1 and 0 M urea renatured rhIL-22BP-ABD, respectively. <strong>D</strong> The reduction of rhIL-22BP using GSSG/GSH redox. M represents protein marker, lane 1 represents the denatured supernatant of rhIL-22BP, lanes 2–5 represent rhIL-22BP and 4, 2, 1 and 0 M urea renatured rhIL-22BP, respectively. <strong>E</strong> Graphs of the results of DTT renaturation of rhIL-22BP-ABD and rhIL-22BP. M represents protein marker, lanes 1–3 represent rhIL-22BP-ABD after purification, rhIL-22BP-ABD after renaturation with 4 M urea, rhIL-22BP-ABD after renaturation with 0 M urea, respectively. Lanes 4–6 represent rhIL-22BP after purification, rhIL-22BP after renaturation with 4 M urea, and rhIL-22BP after renaturation with 0 M urea, respectively</p></figcaption></figure><p id="Par31">To investigate the ideal conditions for protein renaturation, we employed two renaturation methodologies. The first involved a gradient renaturation of urea utilizing the redox pairs of GSH and GSSG, resulting in a renaturation rate of 60–70% for rhIL-22BP-ABD, whereas rhIL-22BP achieved only a 10–20% renaturation rate (Fig. <a href="#Fig3" class="usa-link">3</a>C, D). The secondary denaturation method involves gradient denaturation utilizing urea in conjunction with the reducing agent dithiothreitol (DTT). This denaturation protocol can elevate the denaturation rates of the two proteins to about 100% (Fig. <a href="#Fig3" class="usa-link">3</a>E). The final denaturation conditions consisted of 8 M urea, maintained at 4 ℃ for 4 h, whereas the reduction conditions involved a gradient from 4 M urea to 0 M urea utilizing DTT as the reducing agent.</p></section><section id="Sec20"><h3 class="pmc_sec_title">The identification of rhIL-22BP-ABD</h3>
<p id="Par32">Western blot analysis verified the authenticity of rhIL-22BP-ABD by demonstrating its specific binding to the anti-His-tag antibody, hence confirming effective expression of the histidine tag in the fusion protein (Fig. <a href="#Fig4" class="usa-link">4</a>A). LC-MS/MS was employed to examine the amino acid composition of rhIL-22BP-ABD, revealing a coverage of 91.2% for the amino acid sequence of rhIL-22BP-ABD (Fig. <a href="#Fig4" class="usa-link">4</a>B), thereby demonstrating that the synthesized rhIL-22BP-ABD corresponded with the pre-designed protein sequence. To assess the biological activity of rhIL-22BP-ABD, we initially confirmed that IL-22 may stimulate the proliferation of HaCaT cells in vitro by a dose-response analysis (Fig. <a href="#Fig4" class="usa-link">4</a>C). rhIL-22BP-ABD had no inhibitory effect on the proliferation of HaCaT cells; however, it strongly inhibited cell proliferation triggered by 10 ng/ml IL-22 (Fig. <a href="#Fig4" class="usa-link">4</a>D-E), and this inhibitory effect demonstrated a dose-dependent relationship (Fig. <a href="#Fig4" class="usa-link">4</a>E).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361007_13568_2025_1931_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12361007/c64dffe6df8c/13568_2025_1931_Fig4_HTML.jpg" loading="lazy" id="d33e622" height="465" width="784" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The identification of rhIL-22BP-ABD. <strong>A</strong> rhIL-22BP-ABD was performed on immunoblotting with anti-His-tag antibody by Western blot. <strong>B</strong> Determination of rhIL-22BP-ABD peptide map by mass spectrometry. <strong>C</strong> The effect of 5, 10 and 50 ng/mL IL-22 on the proliferation of HaCaT cells was detected by CCK8 assay. <strong>D</strong> The 50 μg/mL rhIL-22BP-ABD inhibits in vitro HaCaT cell proliferation stimulated by 10 ng/mL IL-22. <strong>E</strong> The inhibitory effect of 10, 50 and 100 μg/mL rhIL-22BP-ABD on HaCaT cell proliferation stimulated by 10 ng/ml IL-22. Quantitative data are presented as mean ± standard deviation (<em>n</em> = 4). Statistical significance is indicated as follows:*<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, ***<em>P</em> &lt; 0.001, ****<em>P</em> &lt; 0.0001, and ns means no significant difference</p></figcaption></figure></section><section id="Sec21"><h3 class="pmc_sec_title">The half-life analysis of rhIL-22BP-ABD</h3>
<p id="Par34">To characterize the half-life of rhIL-22BP-ABD, the His-tag pull-down method was employed to assess the binding affinity between rhIL-22BP-ABD and HSA. The results indicated that rhIL-22BP-ABD exhibits a superior binding affinity for Ni-NTA at equivalent concentrations, while rhIL-22BP-ABD demonstrates a measurable binding affinity with HSA, in contrast to rhIL-22BP (Fig. <a href="#Fig5" class="usa-link">5</a>A-C). The molecular interaction method was employed to evaluate the kinetic binding parameters of rhIL-22BP-ABD and HSA via BLI assay utilizing the Octet system. The results indicated that rhIL-22BP-ABD exhibits a superior binding affinity for HSA, with a dissociation constant of Kd = 1.146 µM, whereas rhIL-22BP demonstrates negligible binding to HSA (Fig. <a href="#Fig5" class="usa-link">5</a>D).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361007_13568_2025_1931_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12361007/cc14f0a8374d/13568_2025_1931_Fig5_HTML.jpg" loading="lazy" id="d33e658" height="498" width="784" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Specific binding of rhIL-22BP-ABD to HSA and determination of its half-life. <strong>A</strong> Washed clutter diagram of rhIL-22BP His-tag pull-down experiments. M represents the protein marker, lanes 1–4 represent the washed sample after rhIL-22BP binding to Ni-NTA, and lanes 5–9 represent the washed sample after HSA binding to rhIL-22BP. <strong>B</strong> Wash diagram of rhIL-22BP-ABD his tag pull-down experiments. M represents the protein marker, lanes 1–4 represent the washed sample after rhIL-22BP-ABD was bound to Ni-NTA, and lanes 5–9 represent the washed sample after HSA was bound to rhIL-22BP-ABD. <strong>C</strong> rhIL-22BP and rhIL-22BP-ABD his-tag pull-down results. M represents protein marker; lane 1 represents unbound rhIL-22BP-ABD, lane 2 represents unbound rhIL-22BP, lane 3 represents unbound HSA, lane 4 represents bound rhIL-22BP-ABD and HSA with Ni-NTA, and lane 5 represents bound rhIL-22BP and HSA with Ni-NTA. <strong>D</strong> The interaction of different concentrations HSA with the same concentration of rhIL-22BP-ABD. <strong>E</strong> The half-life assay of IL-222BP-ABD and rhIL-22BP</p></figcaption></figure><p id="Par36">To ascertain the in vivo pharmacokinetics of rhIL-22BP-ABD, both rhIL-22BP-ABD and rhIL-22BP were administered intraperitoneally at a dosage of 5 mg/kg in female BALB/c mice. The concentration of recombinant protein in serum at various time intervals post-injection was assessed using ELISA. The findings indicated that the serum level of rhIL-22BP-ABD peaked at 1 h, with a maximum concentration of 342.1 ng/mL, followed by a rapid decline from 1 to 8 h and a gradual reduction from 8 to 48 h (Fig. <a href="#Fig5" class="usa-link">5</a>E). Conversely, the in vivo half-life of rhIL-22BP devoid of the ABD domain is rather brief, rendering it undetectable in less than two hours. The pharmacokinetic parameters were assessed utilizing the Microsoft Excel plug-in “PKSolver,” revealing that the in vivo half-life of rhIL-22BP-ABD was 17 h.</p></section><section id="Sec22"><h3 class="pmc_sec_title">rhIL-22BP-ABD weakens the inflammatory phenotype of the mouse psoriasis model induced by imiquimod</h3>
<p id="Par37">To evaluate the in vivo therapeutic efficacy of rhIL-22BP-ABD on psoriasis, we developed an imiquimod-induced psoriasis mouse model by administering 5% imiquimod cream to the depilated dorsal skin of BALB/c mice for nine consecutive days, as depicted in the image (Fig. <a href="#Fig6" class="usa-link">6</a>A). The mice received intraperitoneal injections of recombinant protein at several concentrations starting from the initial day of modeling. In comparison to the model group, rhIL-22BP-ABD at dosages of 5 mg/kg and 10 mg/kg diminished dorsal skin lesions and spleen size in psoriatic mice (Fig. <a href="#Fig6" class="usa-link">6</a>B, C) and reinstated the spleen index (Fig. <a href="#Fig6" class="usa-link">6</a>D). The PASI scores of both groups of mice administered rhIL-22BP-ABD were markedly diminished on the 8th and 9th days in comparison to the model group (Fig. <a href="#Fig6" class="usa-link">6</a>E).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361007_13568_2025_1931_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12361007/0748e9b55d7d/13568_2025_1931_Fig6_HTML.jpg" loading="lazy" id="d33e712" height="589" width="784" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>rhIL-22BP-ABD ameliorates imiquimod-induced psoriasis-like dermatitis. <strong>A</strong> Schematic diagram of psoriasis model and administration cycle. <strong>B</strong> Representative images of skin lesions on the back of mice in each group on day 4 and 8. <strong>C</strong> Representative images of spleen size of mice in each group. <strong>D</strong> Comparison of spleen index in each group. <strong>E</strong> PASI scores of the dorsal skin of each group of mice throughout the modeling process. Quantitative data are presented as mean ± standard deviation (<em>n</em> = 5). Statistical significance is indicated as follows: ****<em>P</em> &lt; 0.0001</p></figcaption></figure><p id="Par39">H&amp;E staining of mouse skin was used to evaluate the anti-inflammatory impact of rhIL-22BP-ABD in psoriatic mice. Figure <a href="#Fig7" class="usa-link">7</a>A illustrates that the model group exhibited neutrophil aggregation abscesses in the stratum corneum, a markedly thickened epidermis, elevated eosinophil levels, and heightened infiltration of dermal inflammatory cells relative to the non-model group, confirming the efficacy of the imiquimod-induced mouse psoriasis model. In the 5 mg/kg rhIL-22BP-ABD group, epidermal thickening occurred exclusively, dermal inflammatory cell infiltration diminished, and the incidence of epidermal abscesses improved. In the 10 mg/kg rhIL-22BP-ABD group, the skin exhibited keratinization just in the stratum corneum, the epidermis became hypertrophied, the infiltration of dermal inflammatory cells diminished, and the incidence of epidermal abscess formation was significantly reduced (Fig. <a href="#Fig7" class="usa-link">7</a>A). In summary, rhIL-22BP-ABD attenuates the inflammatory phenotype in the murine psoriasis model in a dose-dependent manner.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361007_13568_2025_1931_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6b4/12361007/05bfa7356c86/13568_2025_1931_Fig7_HTML.jpg" loading="lazy" id="d33e756" height="595" width="784" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>rhIL-22BP-ABD decreases the expression of pro-inflammatory cytokines and STAT3 signaling pathway in psoriatic mice. <strong>A</strong> The representative images of the H&amp;E-stained skin sections of different treatment groups. <strong>B</strong> Expression of IL-6 in different treatment groups by ELISA (<em>n</em> = 5). <strong>C</strong> Expression of TNF-α in different treatment groups by ELISA (<em>n</em> = 5). <strong>D</strong> The expressions of IL-22, IFN-γ, IL-1β and p-STAT3 proteins in different treatment groups were detected by Western blot. Quantitative data are presented as mean ± standard deviation (<em>n</em> = 5). Statistical significance is indicated as follows: ****<em>P</em> &lt; 0.0001, and ns means no significant difference</p></figcaption></figure></section><section id="Sec500"><h3 class="pmc_sec_title">rhIL-22BP-ABD decreases the expression of pro-inflammatory cytokines and STAT3 signaling pathway in psoriatic mice</h3>
<p id="Par41">To explore the inhibition of rhIL-22BP-ABD on the expression of pro-inflammatory cytokines in psoriasis mice, the levels of IL-6 and TNF-α in the serum of psoriasis mice were detected by ELISA kits, and the results showed that rhIL-22BP-ABD can significantly inhibit the increase of IL-6 and TNF-α in the serum of the inflammatory model, and the inhibitory effect of an injection dose of 10 mg/kg on IL-6 and TNF-α is superior to that of an injection dose of 5 mg/kg, indicating that this inhibitory effect shows a certain dose effect (Fig. <a href="#Fig7" class="usa-link">7</a>B, C).</p>
<p id="Par42">To define the molecular mechanism of rhIL-22BP-ABD’s anti-inflammation effect, Western blot was performed to detect expression of IL-22 and its downstream STAT3 signal molecular in dorsal skin, and the results showed that 10 mg/kg dose of rhIL-22BP-ABD reduced the expression of IL-22, IFN-γ, IL-1β and p-STAT3 in dorsal skin proteins compared with the model group (Fig. <a href="#Fig7" class="usa-link">7</a>D). It is worth noting that the 5 mg/kg dose of rhIL-22BP-ABD has no reducing effect on the expression of related inflammatory factor proteins in dorsal skin proteins and the expression of inflammatory factors in serum, although it at a dose of 5 mg/kg can significantly reduce the spleen index and PASI score.</p></section></section><section id="Sec24"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par43">Psoriasis is an autoimmune dermatological condition, distinguished by clearly demarcated erythematous plaques adorned with white scales (Boehncke and Schön <a href="#CR5" class="usa-link" aria-describedby="CR5">2015</a>; Nestle et al. <a href="#CR30" class="usa-link" aria-describedby="CR30">2009</a>). Significant advancements have been achieved in comprehending the fundamental mechanics of psoriasis, resulting in the creation of diverse therapeutic alternatives. Contemporary therapy approaches for psoriasis focus on alleviating symptoms, enhancing quality of life, and inhibiting disease progression (Armstrong and Read <a href="#CR3" class="usa-link" aria-describedby="CR3">2020</a>; Kaushik and Lebwohl <a href="#CR18" class="usa-link" aria-describedby="CR18">2019</a>). This encompasses topical therapies, phototherapy, systemic medicines, and biologics aimed at specific immune pathways. Notwithstanding progress in psoriasis treatment, numerous difficulties and unmet requirements persist (Lee and Kim <a href="#CR20" class="usa-link" aria-describedby="CR20">2023</a>). Since 2000, biologics have been pivotal in the treatment of psoriasis (Reid and Griffiths <a href="#CR38" class="usa-link" aria-describedby="CR38">2020</a>), with the primary biologics available still functioning by blocking the pathways linked to the principal pathogenic signaling axis, TNF/IL-17/IL-23. While presently available TNF-α inhibitors, IL-17 inhibitors, and IL-23 inhibitors can effectively manage psoriasis to some degree, their adverse effects need consideration. Adalimumab (anti-TNF-α antibody) is presently the preferred first-line biologic for managing psoriasis with psoriatic arthritis; however, it remains linked to adverse effects in rare conditions, including multiple sclerosis, congestive heart failure, opportunistic infections (e.g., tuberculosis), and lupus (Reid and Griffiths <a href="#CR38" class="usa-link" aria-describedby="CR38">2020</a>). Ustekinumab and other agents are presently available as IL-23 inhibitors for psoriasis treatment. The primary adverse effects are nasopharyngitis, upper respiratory tract infection, headache, and weariness (Farhi <a href="#CR8" class="usa-link" aria-describedby="CR8">2010</a>; Nogueira and Torres <a href="#CR32" class="usa-link" aria-describedby="CR32">2019</a>; Tokuyama and Mabuchi <a href="#CR42" class="usa-link" aria-describedby="CR42">2020</a>; Witjes et al. <a href="#CR46" class="usa-link" aria-describedby="CR46">2020</a>). Consequently, the creation of an innovative medicine that effectively treats psoriasis without adverse effects is a pressing task in the biopharmaceutical sector.</p>
<p id="Par44">Multiple studies have shown that IL-22 plays a role in the development and pathophysiology of psoriasis, suggesting that targeting IL-22 could serve as a promising therapeutic approach for treating the condition (Hao <a href="#CR15" class="usa-link" aria-describedby="CR15">2014</a>; Martin et al. <a href="#CR26" class="usa-link" aria-describedby="CR26">2017</a>). IL-22BP is a soluble receptor homolog that exhibits a higher affinity for IL-22 than the membrane-bound receptor, suggesting its potential therapeutic significance in diminishing IL-22 levels in psoriasis (Zenewicz <a href="#CR51" class="usa-link" aria-describedby="CR51">2021</a>). In this study, we successfully engineered a recombinant bacterium that expresses a long-acting rhIL-22BP-ABD protein, comprising human IL-22BP and an ABD domain. This work demonstrated that recombinant protein was expressed in inclusion bodies, which can significantly facilitate future protein purification stages. Nonetheless, recombinant proteins present as inclusion bodies lack biological activity. Consequently, we utilized high-concentration urea-denatured protein, purified it, and delineated the parameters for protein reduction. We employed two strategies for protein gradient reduction: GSH/GSSG redox couples and DTT supplementation. In contrast to the GSH/GSSG redox pairs, DTT offers the benefit of requiring only two gradients of 4 M and 0 M urea for its reduction gradient, resulting in a total replication time that is less than that needed for the GSH/GSSG redox pair. Coversely, the renaturation rates of rhIL-22BP-ABD and IL-22BP proteins approached 100% with DTT, whereas the renaturation rates using GSH/GSSG redox were 60–70% and 10–20%, respectively, yielding a protein concentration insufficient to meet the requirements for subsequent molecular interactions. In conclusion, we ultimately selected DTT for protein renaturation. However, there are differences in biological activity among different batches of this protein in its inclusion body form, which may affect the further verification of its biological activity. During this process, without the assistance of genetic regulation, the protein’s folding will have a certain degree of deviation from its natural conformation. Currently, we have independently prepared three batches of protein samples, all of which show certain biological activity. However, at the same concentration, they did not have a consistent inhibitory effect on the proliferation of the same batch of HacaT cells. Furthermore, when using the <em>Escherichia coli</em> expression system to produce the target protein, the immunogenicity of the protein and the control of endotoxin contamination are the key factors that affect its biological application value. Even a small amount of residual endotoxin can trigger a strong inflammatory response through the activation of the Toll-like receptor 4 (TLR4) signaling pathway (Ciesielska et al. <a href="#CR6" class="usa-link" aria-describedby="CR6">2021</a>; Fu et al. <a href="#CR9" class="usa-link" aria-describedby="CR9">2021</a>), thereby non-specifically enhancing the immunogenicity of the protein. Currently, we thoroughly wash and perform affinity chromatography purification of the inclusion bodies when obtaining them, removing some endotoxin. In the future, we will further control the endotoxin content according to relevant standard requirements to reduce its impact on the immunogenicity of the target protein.</p>
<p id="Par45">Research has established that IL-22 can promote the in vitro proliferation of HaCaT cells (Ma et al. <a href="#CR25" class="usa-link" aria-describedby="CR25">2023</a>; Wang et al. <a href="#CR44" class="usa-link" aria-describedby="CR44">2018</a>), which have been utilized as in vitro models for psoriasis in numerous research (Gao et al. <a href="#CR12" class="usa-link" aria-describedby="CR12">2020</a>; Ma et al. <a href="#CR25" class="usa-link" aria-describedby="CR25">2023</a>; Wang et al. <a href="#CR44" class="usa-link" aria-describedby="CR44">2018</a>). Consequently, we hypothesize that the biological activity of rhIL-22BP-ABD can be assessed by measuring the proliferation rate of IL-22-stimulated HaCaT cells. Our results indicated that rhIL-22BP-ABD did not exhibit an inhibitory effect on the proliferation of HaCaT cells; nevertheless, it dramatically inhibited IL-22-stimulated cell proliferation by antagonizing the binding of IL-22 to its receptor (Fig. <a href="#Fig4" class="usa-link">4</a>D-E).</p>
<p id="Par46">The half-life of human IL-22BP has yet to be documented in the literature. Our findings indicated that the half-life of rhIL-22BP is notably brief, under 2 h (Fig. <a href="#Fig5" class="usa-link">5</a>E). Consequently, the development of a long-acting IL-22BP protein is essential for IL-22BP to fulfill its biological function. The albumin-binding domain (ABD) has demonstrated the ability to extend the half-life of molecular pharmaceuticals (Mester et al. <a href="#CR27" class="usa-link" aria-describedby="CR27">2021</a>; Nikravesh et al. <a href="#CR31" class="usa-link" aria-describedby="CR31">2022</a>). We synthesized the fusion protein rhIL-22BP-ABD, comprising IL-22BP and ABD, using a prokaryotic expression system. We verified that the half-life of rhIL-22BP-ABD was markedly prolonged compared to rhIL-22BP through molecular interaction and half-life assessments, indicating a substantial enhancement in the drug’s stability and efficacy. Despite an 80.8% homology between human IL-22 and mouse IL-22 (Wolk and Sabat <a href="#CR49" class="usa-link" aria-describedby="CR49">2006</a>), the homology between human IL-22BP and mouse IL-22BP was merely 67.1% (Wei et al. <a href="#CR45" class="usa-link" aria-describedby="CR45">2003</a>), suggesting that the binding affinity of rhIL-22BP-ABD to mouse IL-22 is limited. Consequently, the half-life of rhIL-22BP-ABD in the human body may exceed our experimental findings.</p>
<p id="Par47">Any protein can serve as a double-edged sword, and IL-22BP is no exception. Certain findings indicated that elevated levels of IL-22BP result in numerous adverse consequences (Fachi et al. <a href="#CR7" class="usa-link" aria-describedby="CR7">2024</a>). IL-22 enhances intestinal barrier integrity by encouraging epithelial cells to activate defensive mechanisms against enteric infections. In IL-22-deficient animals, IL22BP enhances vulnerability to acute dextran sulfate sodium (DSS) and T-cell-mediated colitis (Zenewicz <a href="#CR51" class="usa-link" aria-describedby="CR51">2021</a>). Conversely, a lack of IL22BP augments the gut microbiota’s capacity to defend against enteric infections (Fachi et al. <a href="#CR7" class="usa-link" aria-describedby="CR7">2024</a>). IL-22 enhances bacterial host defense in the lung by maintaining epithelial integrity and inducing antimicrobial peptides, while its activity is decreased by IL-22BP, indicating that IL-22BP has a pro-inflammatory role and compromises epithelial barrier function, presumably through its binding to IL-22 (Abood et al. <a href="#CR1" class="usa-link" aria-describedby="CR1">2019</a>). Consequently, we performed an initial safety evaluation of rhIL-22BP-ABD. Administration of 10 mg/kg of rhIL-22BP-ABD into healthy BALB/C mice, followed by the assessment of serum AST and ALT levels, along with histological examination of the kidneys, revealed no significant variation in enzyme levels compared to the normal group, as indicated by the renal pathological analysis (Supplementary file 2: Data 1), suggesting a high safety profile for rhIL-22BP-ABD. We will enhance the safety assessment of this medicine in future study. In conclusion, this study effectively produced long-acting rhIL-22BP-ABD using a prokaryotic expression method. This protein can significantly reduce psoriasis inflammation and suppress the IL-22/STAT3 signaling pathway and associated inflammatory factors in mice induced by imiquimod, indicating that rhIL-22BP-ABD holds substantial promise as a potential therapeutic agent for psoriasis treatment.</p></section><section id="Sec25"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12361007/bin/13568_2025_1931_MOESM1_ESM.doc" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (333.5KB, doc) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12361007/bin/13568_2025_1931_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (109.6KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>None.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>XZC performed the experiments, analyzed the data and wrote the manuscript. TZ, QYT, YYL, WLZ and BQG performed the experiments. FF, NT and JZZ revised the manuscript. YCX design the project, revised the manuscript. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was funded by Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515010028, 2024A1515012937).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar3"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par48">All animal experiments conducted in this article were approved by the Laboratory Animal Ethics Committee of Guangdong Medical University.</p></section><section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par49">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ol class="ref-list font-sm">
<li id="CR1">
<cite>Abood RN, McHugh KJ, Rich HE, Ortiz MA, Tobin JM, Ramanan K, Robinson KM, Bomberger JM, Kolls JK, Manni ML, Pociask DA, Alcorn JF (2019) IL-22-binding protein exacerbates influenza, bacterial super-infection. Mucosal Immunol 12(5):1231–1243. 10.1038/s41385-019-0188-7
</cite> [<a href="https://doi.org/10.1038/s41385-019-0188-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6717528/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31296910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abood%20RN,%20McHugh%20KJ,%20Rich%20HE,%20Ortiz%20MA,%20Tobin%20JM,%20Ramanan%20K,%20Robinson%20KM,%20Bomberger%20JM,%20Kolls%20JK,%20Manni%20ML,%20Pociask%20DA,%20Alcorn%20JF%20(2019)%20IL-22-binding%20protein%20exacerbates%20influenza,%20bacterial%20super-infection.%20Mucosal%20Immunol%2012(5):1231%E2%80%931243.%2010.1038/s41385-019-0188-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<cite>Altai M, Leitao CD, Rinne SS, Vorobyeva A, Atterby C, Ståhl S, Tolmachev V, Löfblom J, Orlova A (2018) Influence of molecular design on the targeting properties of ABD-fused mono- and Bi-valent Anti-HER3 affibody therapeutic constructs. Cells 7(10). 10.3390/cells7100164</cite> [<a href="https://doi.org/10.3390/cells7100164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6210767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30314301/" class="usa-link">PubMed</a>]</li>
<li id="CR3">
<cite>Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945–1960. 10.1001/jama.2020.4006
</cite> [<a href="https://doi.org/10.1001/jama.2020.4006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32427307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Armstrong%20AW,%20Read%20C%20(2020)%20Pathophysiology,%20clinical%20presentation,%20and%20treatment%20of%20psoriasis:%20a%20review.%20JAMA%20323(19):1945%E2%80%931960.%2010.1001/jama.2020.4006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<cite>Bleicher L, de Moura PR, Watanabe L, Colau D, Dumoutier L, Renauld JC, Polikarpov I (2008) Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett 582(20):2985–2992. 10.1016/j.febslet.2008.07.046
</cite> [<a href="https://doi.org/10.1016/j.febslet.2008.07.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18675809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bleicher%20L,%20de%20Moura%20PR,%20Watanabe%20L,%20Colau%20D,%20Dumoutier%20L,%20Renauld%20JC,%20Polikarpov%20I%20(2008)%20Crystal%20structure%20of%20the%20IL-22/IL-22R1%20complex%20and%20its%20implications%20for%20the%20IL-22%20signaling%20mechanism.%20FEBS%20Lett%20582(20):2985%E2%80%932992.%2010.1016/j.febslet.2008.07.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<cite>Boehncke WH, Schön MP (2015) Psoriasis. Lancet 386(9997):983–994. 10.1016/s0140-6736(14)61909-7
</cite> [<a href="https://doi.org/10.1016/S0140-6736(14)61909-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26025581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Boehncke%20WH,%20Sch%C3%B6n%20MP%20(2015)%20Psoriasis.%20Lancet%20386(9997):983%E2%80%93994.%2010.1016/s0140-6736(14)61909-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<cite>Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 78(4):1233–1261. 10.1007/s00018-020-03656-y
</cite> [<a href="https://doi.org/10.1007/s00018-020-03656-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7904555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33057840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ciesielska%20A,%20Matyjek%20M,%20Kwiatkowska%20K%20(2021)%20TLR4%20and%20CD14%20trafficking%20and%20its%20influence%20on%20LPS-induced%20pro-inflammatory%20signaling.%20Cell%20Mol%20Life%20Sci%2078(4):1233%E2%80%931261.%2010.1007/s00018-020-03656-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<cite>Fachi JL, Di Luccia B, Gilfillan S, Chang HW, Song C, Cheng J, Cella M, Vinolo MA, Gordon JI, Colonna M (2024) Deficiency of IL-22-binding protein enhances the ability of the gut microbiota to protect against enteric pathogens. Proc Natl Acad Sci USA 121(19):e2321836121. 10.1073/pnas.2321836121
</cite> [<a href="https://doi.org/10.1073/pnas.2321836121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11087805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38687788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fachi%20JL,%20Di%20Luccia%20B,%20Gilfillan%20S,%20Chang%20HW,%20Song%20C,%20Cheng%20J,%20Cella%20M,%20Vinolo%20MA,%20Gordon%20JI,%20Colonna%20M%20(2024)%20Deficiency%20of%20IL-22-binding%20protein%20enhances%20the%20ability%20of%20the%20gut%20microbiota%20to%20protect%20against%20enteric%20pathogens.%20Proc%20Natl%20Acad%20Sci%20USA%20121(19):e2321836121.%2010.1073/pnas.2321836121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<cite>Farhi D (2010) Ustekinumab for the treatment of psoriasis: review of three multicenter clinical trials. Drugs Today (Barc) 46(4):259–264. 10.1358/dot.2010.46.4.1464839
</cite> [<a href="https://doi.org/10.1358/dot.2010.46.4.1464839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20502723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Farhi%20D%20(2010)%20Ustekinumab%20for%20the%20treatment%20of%20psoriasis:%20review%20of%20three%20multicenter%20clinical%20trials.%20Drugs%20Today%20(Barc)%2046(4):259%E2%80%93264.%2010.1358/dot.2010.46.4.1464839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<cite>Fu YJ, Xu B, Huang SW, Luo X, Deng XL, Luo S, Liu C, Wang Q, Chen JY, Zhou L (2021) Baicalin prevents LPS-induced activation of TLR4/NF-κB p65 pathway and inflammation in mice via inhibiting the expression of CD14. Acta Pharmacol Sin 42(1):88–96. 10.1038/s41401-020-0411-9
</cite> [<a href="https://doi.org/10.1038/s41401-020-0411-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7921675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32457419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20YJ,%20Xu%20B,%20Huang%20SW,%20Luo%20X,%20Deng%20XL,%20Luo%20S,%20Liu%20C,%20Wang%20Q,%20Chen%20JY,%20Zhou%20L%20(2021)%20Baicalin%20prevents%20LPS-induced%20activation%20of%20TLR4/NF-%CE%BAB%20p65%20pathway%20and%20inflammation%20in%20mice%20via%20inhibiting%20the%20expression%20of%20CD14.%20Acta%20Pharmacol%20Sin%2042(1):88%E2%80%9396.%2010.1038/s41401-020-0411-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<cite>Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG (2009) Human Langerhans cells induce distinct IL-22-producing CD4 + T cells lacking IL-17 production. Proc Natl Acad Sci USA 106(51):21795–21800. 10.1073/pnas.0911472106
</cite> [<a href="https://doi.org/10.1073/pnas.0911472106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2799849/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19996179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fujita%20H,%20Nograles%20KE,%20Kikuchi%20T,%20Gonzalez%20J,%20Carucci%20JA,%20Krueger%20JG%20(2009)%20Human%20Langerhans%20cells%20induce%20distinct%20IL-22-producing%20CD4%E2%80%89+%E2%80%89T%20cells%20lacking%20IL-17%20production.%20Proc%20Natl%20Acad%20Sci%20USA%20106(51):21795%E2%80%9321800.%2010.1073/pnas.0911472106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<cite>Fukaya T, Fukui T, Uto T, Takagi H, Nasu J, Miyanaga N, Arimura K, Nakamura T, Koseki H, Choijookhuu N, Hishikawa Y, Sato K (2018) Pivotal role of IL-22 binding protein in the epithelial autoregulation of Interleukin-22 signaling in the control of skin inflammation. Front Immunol 9:1418. 10.3389/fimmu.2018.01418
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.01418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6021537/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29977242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fukaya%20T,%20Fukui%20T,%20Uto%20T,%20Takagi%20H,%20Nasu%20J,%20Miyanaga%20N,%20Arimura%20K,%20Nakamura%20T,%20Koseki%20H,%20Choijookhuu%20N,%20Hishikawa%20Y,%20Sato%20K%20(2018)%20Pivotal%20role%20of%20IL-22%20binding%20protein%20in%20the%20epithelial%20autoregulation%20of%20Interleukin-22%20signaling%20in%20the%20control%20of%20skin%20inflammation.%20Front%20Immunol%209:1418.%2010.3389/fimmu.2018.01418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<cite>Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M (2020) Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res 53(1):48. 10.1186/s40659-020-00316-0
</cite> [<a href="https://doi.org/10.1186/s40659-020-00316-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7576854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33081840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20J,%20Chen%20F,%20Fang%20H,%20Mi%20J,%20Qi%20Q,%20Yang%20M%20(2020)%20Daphnetin%20inhibits%20proliferation%20and%20inflammatory%20response%20in%20human%20HaCaT%20keratinocytes%20and%20ameliorates%20imiquimod-induced%20psoriasis-like%20skin%20lesion%20in%20mice.%20Biol%20Res%2053(1):48.%2010.1186/s40659-020-00316-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<cite>Gibbs S (1996) Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol 35(9):633–639. 10.1111/j.1365-4362.1996.tb03687.x
</cite> [<a href="https://doi.org/10.1111/j.1365-4362.1996.tb03687.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8876289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gibbs%20S%20(1996)%20Skin%20disease%20and%20socioeconomic%20conditions%20in%20rural%20Africa:%20Tanzania.%20Int%20J%20Dermatol%2035(9):633%E2%80%93639.%2010.1111/j.1365-4362.1996.tb03687.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<cite>Guo J, Zhang H, Lin W, Lu L, Su J, Chen X (2023) Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther 8(1):437. 10.1038/s41392-023-01655-6
</cite> [<a href="https://doi.org/10.1038/s41392-023-01655-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10679229/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38008779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20J,%20Zhang%20H,%20Lin%20W,%20Lu%20L,%20Su%20J,%20Chen%20X%20(2023)%20Signaling%20pathways%20and%20targeted%20therapies%20for%20psoriasis.%20Signal%20Transduct%20Target%20Ther%208(1):437.%2010.1038/s41392-023-01655-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<cite>Hao JQ (2014) Targeting interleukin-22 in psoriasis. Inflammation 37(1):94–99. 10.1007/s10753-013-9715-y
</cite> [<a href="https://doi.org/10.1007/s10753-013-9715-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23978911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hao%20JQ%20(2014)%20Targeting%20interleukin-22%20in%20psoriasis.%20Inflammation%2037(1):94%E2%80%9399.%2010.1007/s10753-013-9715-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<cite>Jones BC, Logsdon NJ, Walter MR (2008) Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure 16(9):1333–1344. 10.1016/j.str.2008.06.005
</cite> [<a href="https://doi.org/10.1016/j.str.2008.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2637415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18599299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jones%20BC,%20Logsdon%20NJ,%20Walter%20MR%20(2008)%20Structure%20of%20IL-22%20bound%20to%20its%20high-affinity%20IL-22R1%20chain.%20Structure%2016(9):1333%E2%80%931344.%2010.1016/j.str.2008.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<cite>Jonsson A, Dogan J, Herne N, Abrahmsén L, Nygren PA (2008) Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Eng Des Sel 21(8):515–527. 10.1093/protein/gzn028
</cite> [<a href="https://doi.org/10.1093/protein/gzn028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18499681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jonsson%20A,%20Dogan%20J,%20Herne%20N,%20Abrahms%C3%A9n%20L,%20Nygren%20PA%20(2008)%20Engineering%20of%20a%20femtomolar%20affinity%20binding%20protein%20to%20human%20serum%20albumin.%20Protein%20Eng%20Des%20Sel%2021(8):515%E2%80%93527.%2010.1093/protein/gzn028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<cite>Kaushik SB, Lebwohl MG (2019) Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol 80(1):27–40. 10.1016/j.jaad.2018.06.057
</cite> [<a href="https://doi.org/10.1016/j.jaad.2018.06.057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30017705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaushik%20SB,%20Lebwohl%20MG%20(2019)%20Psoriasis:%20which%20therapy%20for%20which%20patient:%20psoriasis%20comorbidities%20and%20preferred%20systemic%20agents.%20J%20Am%20Acad%20Dermatol%2080(1):27%E2%80%9340.%2010.1016/j.jaad.2018.06.057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<cite>Khawar MB, Azam F, Sheikh N, Abdul Mujeeb K (2016) How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis? J Immunol Res 2148129. 10.1155/2016/2148129</cite> [<a href="https://doi.org/10.1155/2016/2148129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5168458/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28050571/" class="usa-link">PubMed</a>]</li>
<li id="CR20">
<cite>Lee HJ, Kim M (2023) Challenges and future trends in the treatment of psoriasis. Int J Mol Sci 24(17). 10.3390/ijms241713313</cite> [<a href="https://doi.org/10.3390/ijms241713313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10487560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37686119/" class="usa-link">PubMed</a>]</li>
<li id="CR21">
<cite>Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC (2002) Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 277(37):33676–33682. 10.1074/jbc.M204204200
</cite> [<a href="https://doi.org/10.1074/jbc.M204204200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12087100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lejeune%20D,%20Dumoutier%20L,%20Constantinescu%20S,%20Kruijer%20W,%20Schuringa%20JJ,%20Renauld%20JC%20(2002)%20Interleukin-22%20(IL-22)%20activates%20the%20JAK/STAT,%20ERK,%20JNK,%20and%20p38%20MAP%20kinase%20pathways%20in%20a%20rat%20hepatoma%20cell%20line.%20Pathways%20that%20are%20shared%20with%20and%20distinct%20from%20IL-10.%20J%20Biol%20Chem%20277(37):33676%E2%80%9333682.%2010.1074/jbc.M204204200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<cite>Li J, Tomkinson KN, Tan XY, Wu P, Yan G, Spaulding V, Deng B, Annis-Freeman B, Heveron K, Zollner R, De Zutter G, Wright JF, Crawford TK, Liu W, Jacobs KA, Wolfman NM, Ling V, Pittman DD, Veldman GM, Fouser LA (2004) Temporal associations between Interleukin 22 and the extracellular domains of IL-22R and IL-10R2. Int Immunopharmacol 4(5):693–708. 10.1016/j.intimp.2004.01.010
</cite> [<a href="https://doi.org/10.1016/j.intimp.2004.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15120653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Tomkinson%20KN,%20Tan%20XY,%20Wu%20P,%20Yan%20G,%20Spaulding%20V,%20Deng%20B,%20Annis-Freeman%20B,%20Heveron%20K,%20Zollner%20R,%20De%20Zutter%20G,%20Wright%20JF,%20Crawford%20TK,%20Liu%20W,%20Jacobs%20KA,%20Wolfman%20NM,%20Ling%20V,%20Pittman%20DD,%20Veldman%20GM,%20Fouser%20LA%20(2004)%20Temporal%20associations%20between%20Interleukin%2022%20and%20the%20extracellular%20domains%20of%20IL-22R%20and%20IL-10R2.%20Int%20Immunopharmacol%204(5):693%E2%80%93708.%2010.1016/j.intimp.2004.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<cite>Li L, Liu X, Ge W, Chen C, Huang Y, Jin Z, Zhan M, Duan X, Liu X, Kong Y, Jiang J, Li X, Zeng X, Li F, Xu S, Li M, Chen H (2022) CB2R deficiency exacerbates Imiquimod-Induced psoriasiform dermatitis and itch through the Neuro-Immune pathway. Front Pharmacol 13:790712. 10.3389/fphar.2022.790712
</cite> [<a href="https://doi.org/10.3389/fphar.2022.790712" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8841964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35173615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20L,%20Liu%20X,%20Ge%20W,%20Chen%20C,%20Huang%20Y,%20Jin%20Z,%20Zhan%20M,%20Duan%20X,%20Liu%20X,%20Kong%20Y,%20Jiang%20J,%20Li%20X,%20Zeng%20X,%20Li%20F,%20Xu%20S,%20Li%20M,%20Chen%20H%20(2022)%20CB2R%20deficiency%20exacerbates%20Imiquimod-Induced%20psoriasiform%20dermatitis%20and%20itch%20through%20the%20Neuro-Immune%20pathway.%20Front%20Pharmacol%2013:790712.%2010.3389/fphar.2022.790712" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<cite>Liu Y, Bai X, Lyu C, Fang J, Zhang F, Wu WH, Wei W, Zhang WB (2022) Mechano-bioconjugation strategy empowering fusion protein therapeutics with aggregation resistance, prolonged circulation, and enhanced antitumor efficacy. J Am Chem Soc 144(40):18387–18396. 10.1021/jacs.2c06532
</cite> [<a href="https://doi.org/10.1021/jacs.2c06532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36178288/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Bai%20X,%20Lyu%20C,%20Fang%20J,%20Zhang%20F,%20Wu%20WH,%20Wei%20W,%20Zhang%20WB%20(2022)%20Mechano-bioconjugation%20strategy%20empowering%20fusion%20protein%20therapeutics%20with%20aggregation%20resistance,%20prolonged%20circulation,%20and%20enhanced%20antitumor%20efficacy.%20J%20Am%20Chem%20Soc%20144(40):18387%E2%80%9318396.%2010.1021/jacs.2c06532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<cite>Ma C, Gu C, Lian P, Wazir J, Lu R, Ruan B, Wei L, Li L, Pu W, Peng Z, Wang W, Zong Y, Huang Z, Wang H, Lu Y, Su Z (2023) Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 pathway activation and attenuating inflammatory signaling. Cell Death Dis 14(11):768. 10.1038/s41419-023-06234-9
</cite> [<a href="https://doi.org/10.1038/s41419-023-06234-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10676357/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38007430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20C,%20Gu%20C,%20Lian%20P,%20Wazir%20J,%20Lu%20R,%20Ruan%20B,%20Wei%20L,%20Li%20L,%20Pu%20W,%20Peng%20Z,%20Wang%20W,%20Zong%20Y,%20Huang%20Z,%20Wang%20H,%20Lu%20Y,%20Su%20Z%20(2023)%20Sulforaphane%20alleviates%20psoriasis%20by%20enhancing%20antioxidant%20defense%20through%20KEAP1-NRF2%20pathway%20activation%20and%20attenuating%20inflammatory%20signaling.%20Cell%20Death%20Dis%2014(11):768.%2010.1038/s41419-023-06234-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<cite>Martin JC, Wolk K, Bériou G, Abidi A, Witte-Händel E, Louvet C, Kokolakis G, Drujont L, Dumoutier L, Renauld JC, Sabat R, Josien R (2017) Limited presence of IL-22 binding protein, a natural IL-22 inhibitor, strengthens psoriatic skin inflammation. J Immunol 198(9):3671–3678. 10.4049/jimmunol.1700021
</cite> [<a href="https://doi.org/10.4049/jimmunol.1700021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28356382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Martin%20JC,%20Wolk%20K,%20B%C3%A9riou%20G,%20Abidi%20A,%20Witte-H%C3%A4ndel%20E,%20Louvet%20C,%20Kokolakis%20G,%20Drujont%20L,%20Dumoutier%20L,%20Renauld%20JC,%20Sabat%20R,%20Josien%20R%20(2017)%20Limited%20presence%20of%20IL-22%20binding%20protein,%20a%20natural%20IL-22%20inhibitor,%20strengthens%20psoriatic%20skin%20inflammation.%20J%20Immunol%20198(9):3671%E2%80%933678.%2010.4049/jimmunol.1700021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<cite>Mester S, Evers M, Meyer S, Nilsen J, Greiff V, Sandlie I, Leusen J, Andersen JT (2021) Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo. MAbs 13(1), 1893888. 10.1080/19420862.2021.1893888
</cite> [<a href="https://doi.org/10.1080/19420862.2021.1893888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7954421/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33691596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mester%20S,%20Evers%20M,%20Meyer%20S,%20Nilsen%20J,%20Greiff%20V,%20Sandlie%20I,%20Leusen%20J,%20Andersen%20JT%20(2021)%20Extended%20plasma%20half-life%20of%20albumin-binding%20domain%20fused%20human%20IgA%20upon%20pH-dependent%20albumin%20engagement%20of%20human%20FcRn%20in%20vitro%20and%20in%20vivo.%20MAbs%2013(1),%201893888.%2010.1080/19420862.2021.1893888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<cite>Mühl H, Bachmann M (2019) IL-18/IL-18BP and IL-22/IL-22BP: two interrelated couples with therapeutic potential. Cell Signal 63:109388. 10.1016/j.cellsig.2019.109388
</cite> [<a href="https://doi.org/10.1016/j.cellsig.2019.109388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31401146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?M%C3%BChl%20H,%20Bachmann%20M%20(2019)%20IL-18/IL-18BP%20and%20IL-22/IL-22BP:%20two%20interrelated%20couples%20with%20therapeutic%20potential.%20Cell%20Signal%2063:109388.%2010.1016/j.cellsig.2019.109388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<cite>Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R (2004) Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 4(5):679–691. 10.1016/j.intimp.2004.01.008
</cite> [<a href="https://doi.org/10.1016/j.intimp.2004.01.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15120652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagalakshmi%20ML,%20Rascle%20A,%20Zurawski%20S,%20Menon%20S,%20de%20Waal%20Malefyt%20R%20(2004)%20Interleukin-22%20activates%20STAT3%20and%20induces%20IL-10%20by%20colon%20epithelial%20cells.%20Int%20Immunopharmacol%204(5):679%E2%80%93691.%2010.1016/j.intimp.2004.01.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<cite>Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361(5):496–509. 10.1056/NEJMra0804595
</cite> [<a href="https://doi.org/10.1056/NEJMra0804595" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19641206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nestle%20FO,%20Kaplan%20DH,%20Barker%20J%20(2009)%20Psoriasis.%20N%20Engl%20J%20Med%20361(5):496%E2%80%93509.%2010.1056/NEJMra0804595" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<cite>Nikravesh FY, Shirkhani S, Bayat E, Talebkhan Y, Mirabzadeh E, Sabzalinejad M, Aliabadi HAM, Nematollahi L, Ardakani YH, Sardari S (2022) Extension of human GCSF serum half-life by the fusion of albumin binding domain. Sci Rep 12(1):667. 10.1038/s41598-021-04560-6
</cite> [<a href="https://doi.org/10.1038/s41598-021-04560-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8758692/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35027593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nikravesh%20FY,%20Shirkhani%20S,%20Bayat%20E,%20Talebkhan%20Y,%20Mirabzadeh%20E,%20Sabzalinejad%20M,%20Aliabadi%20HAM,%20Nematollahi%20L,%20Ardakani%20YH,%20Sardari%20S%20(2022)%20Extension%20of%20human%20GCSF%20serum%20half-life%20by%20the%20fusion%20of%20albumin%20binding%20domain.%20Sci%20Rep%2012(1):667.%2010.1038/s41598-021-04560-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<cite>Nogueira M, Torres T (2019) Guselkumab for the treatment of psoriasis—evidence to date. Drugs Context 8:212594. 10.7573/dic.212594
</cite> [<a href="https://doi.org/10.7573/dic.212594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6668503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31391856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nogueira%20M,%20Torres%20T%20(2019)%20Guselkumab%20for%20the%20treatment%20of%20psoriasis%E2%80%94evidence%20to%20date.%20Drugs%20Context%208:212594.%2010.7573/dic.212594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<cite>Owen CM, Chalmers RJ, O’Sullivan T, Griffiths CE (2000) Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 2Cd001976. 10.1002/14651858.Cd001976</cite> [<a href="https://doi.org/10.1002/14651858.CD001976" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10796842/" class="usa-link">PubMed</a>]</li>
<li id="CR34">
<cite>Parisi R, Symmons DP, Griffiths CE, Ashcroft DM (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133(2):377–385. 10.1038/jid.2012.339
</cite> [<a href="https://doi.org/10.1038/jid.2012.339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23014338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parisi%20R,%20Symmons%20DP,%20Griffiths%20CE,%20Ashcroft%20DM%20(2013)%20Global%20epidemiology%20of%20psoriasis:%20a%20systematic%20review%20of%20incidence%20and%20prevalence.%20J%20Invest%20Dermatol%20133(2):377%E2%80%93385.%2010.1038/jid.2012.339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<cite>Pelczar P, Witkowski M, Perez LG, Kempski J, Hammel AG, Brockmann L, Kleinschmidt D, Wende S, Haueis C, Bedke T, Witkowski M, Krasemann S, Steurer S, Booth CJ, Busch P, König A, Rauch U, Benten D, Izbicki JR, Huber S (2016) A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease. Science 354(6310):358–362. 10.1126/science.aah5903
</cite> [<a href="https://doi.org/10.1126/science.aah5903" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27846573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pelczar%20P,%20Witkowski%20M,%20Perez%20LG,%20Kempski%20J,%20Hammel%20AG,%20Brockmann%20L,%20Kleinschmidt%20D,%20Wende%20S,%20Haueis%20C,%20Bedke%20T,%20Witkowski%20M,%20Krasemann%20S,%20Steurer%20S,%20Booth%20CJ,%20Busch%20P,%20K%C3%B6nig%20A,%20Rauch%20U,%20Benten%20D,%20Izbicki%20JR,%20Huber%20S%20(2016)%20A%20pathogenic%20role%20for%20T%20cell-derived%20IL-22BP%20in%20inflammatory%20bowel%20disease.%20Science%20354(6310):358%E2%80%93362.%2010.1126/science.aah5903" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<cite>Perera GK, Di Meglio P, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7:385–422. 10.1146/annurev-pathol-011811-132448
</cite> [<a href="https://doi.org/10.1146/annurev-pathol-011811-132448" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22054142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perera%20GK,%20Di%20Meglio%20P,%20Nestle%20FO%20(2012)%20Psoriasis.%20Annu%20Rev%20Pathol%207:385%E2%80%93422.%2010.1146/annurev-pathol-011811-132448" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<cite>Petit RG, Cano A, Ortiz A, Espina M, Prat J, Muñoz M, Severino P, Souto EB, García ML, Pujol M, Sánchez-López E (2021) Psoriasis: from pathogenesis to pharmacological and nano-technological-based therapeutics. Int J Mol Sci 22(9). 10.3390/ijms22094983</cite> [<a href="https://doi.org/10.3390/ijms22094983" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8125586/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34067151/" class="usa-link">PubMed</a>]</li>
<li id="CR38">
<cite>Reid C, Griffiths CEM (2020) Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol 100(3):adv00032. 10.2340/00015555-3386
</cite> [<a href="https://doi.org/10.2340/00015555-3386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9128930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31971601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reid%20C,%20Griffiths%20CEM%20(2020)%20Psoriasis%20and%20treatment:%20past,%20present%20and%20future%20aspects.%20Acta%20Derm%20Venereol%20100(3):adv00032.%2010.2340/00015555-3386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<cite>Schön MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352(18):1899–1912. 10.1056/NEJMra041320
</cite> [<a href="https://doi.org/10.1056/NEJMra041320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15872205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sch%C3%B6n%20MP,%20Boehncke%20WH%20(2005)%20Psoriasis.%20N%20Engl%20J%20Med%20352(18):1899%E2%80%931912.%2010.1056/NEJMra041320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<cite>Sieminska I, Pieniawska M, Grzywa TM (2024) The immunology of Psoriasis-current concepts in pathogenesis. Clin Rev Allergy Immunol 66(2):164–191. 10.1007/s12016-024-08991-7
</cite> [<a href="https://doi.org/10.1007/s12016-024-08991-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11193704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38642273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sieminska%20I,%20Pieniawska%20M,%20Grzywa%20TM%20(2024)%20The%20immunology%20of%20Psoriasis-current%20concepts%20in%20pathogenesis.%20Clin%20Rev%20Allergy%20Immunol%2066(2):164%E2%80%93191.%2010.1007/s12016-024-08991-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<cite>Tokura Y, Mori T, Hino R (2010) Psoriasis and other Th17-mediated skin diseases. J Uoeh 32(4):317–328. 10.7888/juoeh.32.317
</cite> [<a href="https://doi.org/10.7888/juoeh.32.317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21226422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tokura%20Y,%20Mori%20T,%20Hino%20R%20(2010)%20Psoriasis%20and%20other%20Th17-mediated%20skin%20diseases.%20J%20Uoeh%2032(4):317%E2%80%93328.%2010.7888/juoeh.32.317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<cite>Tokuyama M, Mabuchi T (2020) New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci 21(20). 10.3390/ijms21207488</cite> [<a href="https://doi.org/10.3390/ijms21207488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7589905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33050592/" class="usa-link">PubMed</a>]</li>
<li id="CR43">
<cite>Voglis S, Moos S, Kloos L, Wanke F, Zayoud M, Pelczar P, Giannou AD, Pezer S, Albers M, Luessi F, Huber S, Schäkel K, Kurschus FC (2018) Regulation of IL-22BP in psoriasis. Sci Rep 8(1):5085. 10.1038/s41598-018-23510-3
</cite> [<a href="https://doi.org/10.1038/s41598-018-23510-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5865214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29572462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Voglis%20S,%20Moos%20S,%20Kloos%20L,%20Wanke%20F,%20Zayoud%20M,%20Pelczar%20P,%20Giannou%20AD,%20Pezer%20S,%20Albers%20M,%20Luessi%20F,%20Huber%20S,%20Sch%C3%A4kel%20K,%20Kurschus%20FC%20(2018)%20Regulation%20of%20IL-22BP%20in%20psoriasis.%20Sci%20Rep%208(1):5085.%2010.1038/s41598-018-23510-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<cite>Wang F, Wang J, Zhang Z, Chen S (2018) Tetrandrine inhibits the proliferation and cytokine production induced by IL-22 in HaCaT cells. J Int Med Res 46(12):5210–5218. 10.1177/0300060518801463
</cite> [<a href="https://doi.org/10.1177/0300060518801463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6300934/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30428756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20F,%20Wang%20J,%20Zhang%20Z,%20Chen%20S%20(2018)%20Tetrandrine%20inhibits%20the%20proliferation%20and%20cytokine%20production%20induced%20by%20IL-22%20in%20HaCaT%20cells.%20J%20Int%20Med%20Res%2046(12):5210%E2%80%935218.%2010.1177/0300060518801463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<cite>Wei CC, Ho TW, Liang WG, Chen GY, Chang MS (2003) Cloning and characterization of mouse IL-22 binding protein. Genes Immun 4(3):204–211. 10.1038/sj.gene.6363947
</cite> [<a href="https://doi.org/10.1038/sj.gene.6363947" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12700595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20CC,%20Ho%20TW,%20Liang%20WG,%20Chen%20GY,%20Chang%20MS%20(2003)%20Cloning%20and%20characterization%20of%20mouse%20IL-22%20binding%20protein.%20Genes%20Immun%204(3):204%E2%80%93211.%2010.1038/sj.gene.6363947" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<cite>Witjes H, Khatri A, Diderichsen PM, Mandema J, Othman AA (2020) Meta-Analyses of clinical efficacy of Risankizumab and adalimumab in chronic plaque psoriasis: supporting evidence of Risankizumab superiority. Clin Pharmacol Ther 107(2):435–442. 10.1002/cpt.1624
</cite> [<a href="https://doi.org/10.1002/cpt.1624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7006886/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31502263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Witjes%20H,%20Khatri%20A,%20Diderichsen%20PM,%20Mandema%20J,%20Othman%20AA%20(2020)%20Meta-Analyses%20of%20clinical%20efficacy%20of%20Risankizumab%20and%20adalimumab%20in%20chronic%20plaque%20psoriasis:%20supporting%20evidence%20of%20Risankizumab%20superiority.%20Clin%20Pharmacol%20Ther%20107(2):435%E2%80%93442.%2010.1002/cpt.1624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<cite>Wolk K, Sabat R (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17(5):367–380. 10.1016/j.cytogfr.2006.09.001
</cite> [<a href="https://doi.org/10.1016/j.cytogfr.2006.09.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17030002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wolk%20K,%20Sabat%20R%20(2006)%20Interleukin-22:%20a%20novel%20T-%20and%20NK-cell%20derived%20cytokine%20that%20regulates%20the%20biology%20of%20tissue%20cells.%20Cytokine%20Growth%20Factor%20Rev%2017(5):367%E2%80%93380.%2010.1016/j.cytogfr.2006.09.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<cite>Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R (2004) IL-22 increases the innate immunity of tissues. Immunity 21(2):241–254. 10.1016/j.immuni.2004.07.007
</cite> [<a href="https://doi.org/10.1016/j.immuni.2004.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15308104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wolk%20K,%20Kunz%20S,%20Witte%20E,%20Friedrich%20M,%20Asadullah%20K,%20Sabat%20R%20(2004)%20IL-22%20increases%20the%20innate%20immunity%20of%20tissues.%20Immunity%2021(2):241%E2%80%93254.%2010.1016/j.immuni.2004.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<cite>Wolk K, Haugen HS, Xu W, Witte E, Waggie K, Anderson M, Vom Baur E, Witte K, Warszawska K, Philipp S, Johnson-Leger C, Volk HD, Sterry W, Sabat R (2009) IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) 87(5):523–536. 10.1007/s00109-009-0457-0
</cite> [<a href="https://doi.org/10.1007/s00109-009-0457-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19330474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wolk%20K,%20Haugen%20HS,%20Xu%20W,%20Witte%20E,%20Waggie%20K,%20Anderson%20M,%20Vom%20Baur%20E,%20Witte%20K,%20Warszawska%20K,%20Philipp%20S,%20Johnson-Leger%20C,%20Volk%20HD,%20Sterry%20W,%20Sabat%20R%20(2009)%20IL-22%20and%20IL-20%20are%20key%20mediators%20of%20the%20epidermal%20alterations%20in%20psoriasis%20while%20IL-17%20and%20IFN-gamma%20are%20not.%20J%20Mol%20Med%20(Berl)%2087(5):523%E2%80%93536.%2010.1007/s00109-009-0457-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<cite>Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL (2000) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275(40):31335–31339. 10.1074/jbc.M005304200
</cite> [<a href="https://doi.org/10.1074/jbc.M005304200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10875937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie%20MH,%20Aggarwal%20S,%20Ho%20WH,%20Foster%20J,%20Zhang%20Z,%20Stinson%20J,%20Wood%20WI,%20Goddard%20AD,%20Gurney%20AL%20(2000)%20Interleukin%20(IL)-22,%20a%20novel%20human%20cytokine%20that%20signals%20through%20the%20interferon%20receptor-related%20proteins%20CRF2-4%20and%20IL-22R.%20J%20Biol%20Chem%20275(40):31335%E2%80%9331339.%2010.1074/jbc.M005304200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<cite>Zenewicz LA (2021) IL-22 binding protein (IL-22BP) in the regulation of IL-22 biology. Front Immunol 12:766586. 10.3389/fimmu.2021.766586
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.766586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8634938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34868019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zenewicz%20LA%20(2021)%20IL-22%20binding%20protein%20(IL-22BP)%20in%20the%20regulation%20of%20IL-22%20biology.%20Front%20Immunol%2012:766586.%2010.3389/fimmu.2021.766586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12361007/bin/13568_2025_1931_MOESM1_ESM.doc" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (333.5KB, doc) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12361007/bin/13568_2025_1931_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (109.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from AMB Express are provided here courtesy of <strong>Springer-Verlag</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13568-025-01931-4"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13568_2025_Article_1931.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12361007/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12361007/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12361007%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361007/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12361007/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12361007/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40824430/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12361007/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40824430/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12361007/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12361007/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="eWx49U9Qoc2j6vTptuOfkQJnIiX7kMvTdrxjkT37wfXGVLIENrGkmFBMQYjbjqVz">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
